Skip to Main content Skip to Navigation
New interface
Conference poster

At Which Point and for Which Reasons Are Oral MTX Formulations Switched to Injectable Ones in RA Patients? Combined Results from 3 Independent Observational and Clinical Trials

Document type :
Conference poster
Complete list of metadata

https://hal.univ-brest.fr/hal-01950293
Contributor : Geneviève Michel Connect in order to contact the contributor
Submitted on : Monday, December 10, 2018 - 4:35:30 PM
Last modification on : Tuesday, November 29, 2022 - 5:10:07 PM

Identifiers

  • HAL Id : hal-01950293, version 1

Citation

Rm Flipo, A. Saraux, Christophe Hudry, C Gaujoux-Viala, E Senbel, et al.. At Which Point and for Which Reasons Are Oral MTX Formulations Switched to Injectable Ones in RA Patients? Combined Results from 3 Independent Observational and Clinical Trials. ACR/ARHP Annual Meeting, Oct 2018, Chicago, United States. 70 (suppl 10) (Abstract 601), Arthritis Rheumatology. ⟨hal-01950293⟩

Share

Metrics

Record views

58